Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Mason Barge who wrote (223)	9/29/1998 5:26:00 AM
From: Jim Cash	Read Replies (4) \| Respond to of 422

"continue to exceed our instrument placement projections" Very promising indeed.. I have been hearing that they have exceeded projections also. It is good to hear it from the prez.

To: Mason Barge who wrote (223)	9/29/1998 6:23:00 AM
From: Thomas Kirwin	Respond to of 422

Bullish Indicators Mason, While I also found the letter excessively upbeat it appears as though Ed Gallup has opened the lines of communication substantially with his commitment to provide regular quarterly updates. The stock is positioned well for any positive announcement as is evident by the chart and various technical indicators. ClearStation clearstation.com EquityTrader www1.wsrn.com Go Immucor! Regards, Tom

To: Mason Barge who wrote (223)	9/29/1998 11:09:00 PM
From: technetx	Read Replies (2) \| Respond to of 422

Mason, I agree , things look very positive, but we must not lose sight of the fact that the revenue from these sales,i.e Rosys, may not be reflected substantially in the EPS until the 3rd quarter. I don't want stockholders to be overly optimistic about the earnings report due in October. However, I do believe EPS will be greater than last quarter , and better than the corresponding quarter last year. Dominic

To: Mason Barge who wrote (223)	10/3/1998 1:05:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Information Agent - Beacon Hill Partners, Inc. The September 25 tender offer commencement press release from Immucor also states that Beacon Hill Partners, Inc. is acting as the Information Agent. Their web site may be reviewed by following the link below. bhpweb.com I wonder if they will be soliciting institutional investors as an adjunct to their information agent capacity. If the recent news flurry regarding the tender offer and Gamma Biologicals acquisition is an example of this firm's handy work I am impressed. bhpweb.com Regards, Tom